HEcoPerMed stands for “Healthcare- and pharma-economics in support of the International Consortium for Personalised Medicine – ICPerMed". The project responds to the demand for economic models that evaluate treatments made possible through innovations in personalised medicine. HEcoPerMed also seeks to identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations. HEcoPerMed goes beyond current assessment and payment models in order to serve the need of personalised medicine for more comprehensive cost-effectiveness estimates – incorporating patient and societal perspectives – and for sustainable affordability of cutting-edge health innovations.

What is the aim of HEcoPerMed?

Our project aims to identify the best modelling and payment strategies for personalised medicine to differentiate between promises and reality.

Guidance on health economic modelling

Personalised medicine aims to optimally match patient and treatment by assessing the characteristics of patients related to treatment effectiveness.

Application of best practice health economic modelling in personalised medicine

Develop cost-effectiveness and budget impact models for three case studies by using publicly available input data.

Financing and payment models

Identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations.

Benefits and challenges for European health care

Assess the role and relevance of personalised medicine for the future of the European Social Models of Health Care.

Dissemination and communication

Disseminate the obtained results and organise two scientific workshops and a stakeholder conference.

Project partners

The project consortium consists of six partners from five European countries.

Latest News

1st HecoPerMed Workshop on April 21st to April 23rd 2021

Personalised medicine (PM) specific health economic and payment modelling

Unfortunately, the first HecoPerMed workshop with the title “Personalised medicine (PM) specific health economic and payment modelling” had to be postponed due to the ongoing global Covid-19 pandemic in order to ensure safety as well as the participation of all invited experts and stakeholders. Also, the concept and aim of the event are dependent on the face to face exchange and discussion and is less suitable for an online or conference call format. Thus, the workshop is postponed to April 21st to April 23rd 2021 in Budapest, Hungary. We will report on the event on our website.

Project kick-off meeting HEcoPerMed

Group picture

The macro-economic perspective on Personalised Medicine and what it can do for European Health Systems is still an unsolved matter. The HEcoPerMed project is dedicated to this challenge in the context of health economics and policy making. The official kick-off event of this EU Horizon 2020 project took place from 28 to 29 January in Brussels. All partners got together in order to discuss the implementation of the action and to define next steps and public events.

The HEcoPerMed project started on 1st January 2019 under the coordination of AIT Austrian Institute of Technology, Center for Innovation Systems and Policy. Partners also include the AIT Center for Health & Bioresources the German Aerospace Center e.V. (DLR), the Institute for Medical Technology Assessment and the Erasmus University Rotterdam, the Syreon Research Institute, Budapest, and the University of Oxford.